4/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
4/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
批准号:
8728310
负责人:
James M. Gold
金额:
$19.32万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-30 至 2017-06-30
关键词:
Activities of Daily LivingAddressAffectiveAnhedoniaBehaviorBehavioralBipolar DisorderBrainClinicalClinical TrialsCognitionCognitiveComplementCorpus striatum structureDataData CollectionDevelopmentDiagnosisDiagnosticDimensionsDiseaseDorsalEmotionalEnsureFeedbackFloorFundingFutureGoalsGoldImpairmentIndividualIndividual DifferencesLearningLengthLinkLongitudinal StudiesMaintenanceMajor Mental IllnessMeasuresModificationMood DisordersMoodsNational Institute of Mental HealthNegative ReinforcementsNeurobiologyNeurosciencesOutcomeParietalParticipantPathologyPathway interactionsPerceptionPerformancePositive ReinforcementsProcessPsychological reinforcementPsychometricsPsychopathologyPsychotic DisordersPsychotic Mood DisordersRecruitment ActivityRecurrenceResearch Domain CriteriaResearch InfrastructureResearch PersonnelResourcesRetrievalReversal LearningSamplingSchizoaffective DisordersSchizophreniaSensitivity and SpecificityShort-Term MemorySiteStrategic PlanningStreamSupport SystemSymptomsSystemTask PerformancesTestingTimeVisualVisual system structureWorkbaseclinical applicationcognitive functioncognitive neurosciencecognitive systemeffective therapyfunctional disabilityfunctional outcomesinsightinterestmeetingspublic health relevancerelating to nervous systemresponsereward circuitryreward processingtheoriestherapy developmenttoolworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Clinical neuroscience is on the verge of a revolution. Traditional conceptualizations of disorders based on phenomenology are increasingly recognized as limited, but we have lacked a clear path toward a more valid approach. The Research Domain Criteria (RDoC) initiative has identified one such pathway; the examination of components of behavior linked to known neural systems that form the basis of core dimensions of psychopathology. This competing renewal will provide new insights into the cognitive and emotional processes underlying core symptom dimensions in major mental illness and provide a new set of valid and reliable tools to facilitate the aims of RDoC and Objective 1.4 of the NIMH Strategic Plan: "Develop new ways of classifying disorders based on dimensions of observable behaviors and brain functions." This application will utilize the CNTRaC's infrastructure and expertise to optimize measures of WM capacity, positive and negative reinforcement learning (both implicit and explicit) and reversal learning, and then apply them together with previously validated measures. Specific Aim 1 is to validate (in individuals with schizophrenia, schizoaffective disorder and bipolar disorder, as well as comparison participants) optimized versions of the paradigms that assess our six constructs of interest, as well as to examine the relationship of task performance to clinical and functional outcomes in psychosis. Specific Aim 2 will be to assess and optimize test-retest reliability and practice effects for the task versions validated in Specific Aim 1. Specific Aim 3 will be to use these optimized measures of working memory capacity and reinforcement learning, along with our previously optimized measures of WM goal maintenance, relational encoding and retrieval, and visual integration to examine the relationship between performance on these measures of core constructs and dimensions of psychopathology across diagnoses (including medicated and un-medicated individuals with schizophrenia and schizoaffective disorders, as well as individuals with bipolar disorder). We hypothesize that impairments in the dorsal frontal- parietal and frontal-temporal systems supporting WM (capacity and goal maintenance) and relational encoding/retrieval contribute to disorganization symptoms and functional impairment and that these impairments and relationships cut across affective and non-affective disorder boundaries, forming a core dimension that helps explain the overlap in function and neurobiology across disorders. We also hypothesize that impairments in orbital frontal-striatal systems supporting reinforcement and reversal learning contribute to the negative symptoms of anhedonia/amotivation, which also cut across diagnostic boundaries. However, we hypothesize that anhedonia/amotivation may involve different aspects of reward processing and circuitry in primary mood versus non-mood disorders with our selection of measures motivated to test this hypothesis. We hypothesize that impaired visual integration, which is thought to reflect reduced horizontal and recurrent feedback, will be related to disorganized symptoms across disorders, but will not relate to mood pathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
1/5 CAPER: Computerized Assessment of ProdromE Risk
-
批准号:10569600
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2020
-
负责人:James M. Gold
-
依托单位:
1/5 CAPER: Computerized Assessment of ProdromE Risk
-
批准号:10371050
-
项目类别:
-
资助金额:$59.09万
-
财政年份:2020
-
负责人:James M. Gold
-
依托单位:
1/5 CAPER: Computerized Assessment of ProdromE Risk
-
批准号:9975396
-
项目类别:
-
资助金额:$58.96万
-
财政年份:2020
-
负责人:James M. Gold
-
依托单位:
4/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
-
批准号:7847800
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2010
-
负责人:James M. Gold
-
依托单位:
ATTENTION AND WORKING MEMORY IN SCHIZOPHRENIA
-
批准号:7951150
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2009
-
负责人:James M. Gold
-
依托单位:
EVENT-RELATED POTENTIAL IN SCHIZOPHRENIA DURING VISUAL SEARCH
-
批准号:7951143
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2009
-
负责人:James M. Gold
-
依托单位:
4/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
-
批准号:8575234
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
Clinical and Computational Studies of Dopamine Function in Schizophrenia
-
批准号:8499536
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
Clinical and Computational Studies of Dopamine Function in Schizophrenia
-
批准号:9276769
-
项目类别:
-
资助金额:$60.53万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
Clinical and Computational Studies of Dopamine Function in Schizophrenia
-
批准号:9441146
-
项目类别:
-
资助金额:$13.49万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
4/5-Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium
-
批准号:10661589
-
项目类别:
-
资助金额:$50.88万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
4/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
-
批准号:7693696
-
项目类别:
-
资助金额:$12.3万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
Clinical and Computational Studies of Dopamine Function in Schizophrenia
-
批准号:9107505
-
项目类别:
-
资助金额:$62.17万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
Clinical and Computational Studies of Dopamine Function in Schizophrenia
-
批准号:8019024
-
项目类别:
-
资助金额:$64.29万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
Clinical and Computational Studies of Dopamine Function in Schizophrenia
-
批准号:8212436
-
项目类别:
-
资助金额:$63.56万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
Clinical and Computational Studies of Dopamine Function in Schizophrenia
-
批准号:7761731
-
项目类别:
-
资助金额:$65.03万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
4/5-Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium
-
批准号:9813693
-
项目类别:
-
资助金额:$59.01万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
4/5-Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium
-
批准号:10442429
-
项目类别:
-
资助金额:$52.36万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
4/5-Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium
-
批准号:10006035
-
项目类别:
-
资助金额:$54.96万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
Clinical and Computational Studies of Dopamine Function in Schizophrenia
-
批准号:7575114
-
项目类别:
-
资助金额:$63.65万
-
财政年份:2008
-
负责人:James M. Gold
-
依托单位:
海外基金